NexOptic Provides Corporate Update and Announces Proposed Private Placement Offering

In This Article:

VANCOUVER, BC / ACCESSWIRE / October 24, 2024 / NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE:NXO)(OTCQB:NXOPF)(FSE:E3O1), a company developing cutting-edge AI and imaging technologies is pleased to provide a corporate update and to announce that it intends to complete a non-brokered private placement offering for gross proceeds of up to $1,000,000 (the "Offering").

Corporate Update

Effective May 8, 2024, the Exchange suspended trading in NexOptic's Common Shares as a result of a Cease Trade Order ("CTO") issued by the British Columbia Securities Commission for NexOptic's failure to file its annual audited financial statements, annual MD&A, and certifications for the year ended December 31, 2023. Subsequently the CTO was revoked on June 17, 2024. The Company has applied for reinstatement to trading with the TSXV Venture Exchange (the "Exchange"), and the Company expects that its stock will resume trading on or about October 28, 2024.

The late filing was partially a result of the time it took for MNP LLP, the Company's successor auditor, to complete their first audit of the Company, including the decision to reclassify certain historic income of NexOptic on review of the Company's contracts. NexOptic appreciates the thoroughness of MNP's auditing standards and does not foresee delays in subsequent audits going forward and anticipates a long working relationship with MNP LLP.

Further, NexOptic has recently overcome various transitory challenges related to the departure of and disputes between certain former technical management of the Company, which resulted in delays in NexOptic's business and corporate affairs. With these challenges subsequently resolved, NexOptic looks to its future which includes recapitalizing NexOptic, pursuing its objective of being a leader in AI and medical imaging enhancement software and executing its business and operational objectives.

Notwithstanding such challenges, the Company has established methods and networks that will streamline and advance its operations more cost effectively and expeditiously going forward; further, NexOptic has enhanced its AI and software patent portfolio over the past 12 months by expanding into other leading operating jurisdictions, globally.

NexOptic anticipates realizing revenue as early as this quarter within the medical imaging sector, and management intends to capitalize on this commercialization milestone by expanding the NexOptic team and using the networks of its existing team to complete additional commercial agreements.